Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
6.17
-0.03 (-0.48%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Starling Oncology Market Cap
Starling Oncology has a market cap or net worth of $628.82 million as of September 11, 2026. Its market cap has increased by 114.86% in one year.
Market Cap
628.82M
Enterprise Value
692.52M
1-Year Change
114.86%
Ranking
Category
Stock Price
$6.17
ChartMarket Cap Chart
Since July 23, 2021, Starling Oncology's market cap has increased from $990.00 to $628.82M, an increase of 63,517,317.17%. That is a compound annual growth rate of 1,245.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 628.82M | 79.54% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| agilon health | 1.51B |
| InnovAge Holding | 1.47B |
| Nutex Health | 1.37B |
| The Pennant Group | 1.37B |
| AMN Healthcare Services | 1.29B |
| U.S. Physical Therapy | 1.17B |
| GMR Solutions | 993.28M |
| Charming Medical | 504.26M |